Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ces symbols : NVS save search
Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
Published: 2022-02-18 (Crawled : 07:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -0.9%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -0.33%
europe ces
AavantiBio Announces Formation of Scientific Advisory Board
Published: 2022-02-09 (Crawled : 14:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
IBIO | $1.9 0.0% 99K
|
Health Technology
|
| O: 2.98%
H: 0.0%
C: 0.0%
ces
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.